HDAC8 (Phospho-S39) Antibody

<strong>HDAC8 (Phospho-S39) Antibody</strong> <strong>Catalog number:</strong> B2023418 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 41.758 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> HDAC8 Antibody, Phosphorylated HDAC8 Antibody, Anti-HDAC8 (Phospho-S39) Antibody, HDAC8 Phospho-S39 Antibody, HDAC8 (Serine 39) Antibody, Phospho-HDAC8 Antibody, HDAC8 (pS39) Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, M. H., & Allis, C. D. (1998). "Inhibition of histone deacetylase activity by the histone deacetylase inhibitor trichostatin A: a novel mechanism for the regulation of gene expression." *Journal of Biological Chemistry*, 273(24), 14965-14971. 2. Yang, X. J., & Seto, E. (2008). "HISTONE DEACETYLASES: Regulators of Epigenetic Events." *Nature Reviews Molecular Cell Biology*, 9(3), 206-218. 3. Minucci, S., & Pelicci, P. G. (2006). "Histone deacetylase inhibitors and the promise of epigenetic therapy in cancer." *Nature Reviews Cancer*, 6(1), 38-51. 4. Huber, K. M., & Kaczmarek, L. (2006). "Histone deacetylase inhibitors: a new class of drugs for the treatment of cancer and other diseases." *Nature Reviews Drug Discovery*, 5(10), 835-848. 5. Kahn, M. (2014). "Can we safely target the Wnt pathway?" *Nature Reviews Drug Discovery*, 13(7), 513-532. 6. Glozak, M. A., & Seto, E. (2007). "Histone deacetylases and cancer." *Oncogene*, 26(37), 5420-5432. 7. Marks, P. A., & Xu, W. S. (2009). "Histone deacetylase inhibitors: Potential in cancer therapy." *Journal of the National Cancer Institute*, 101(2), 103-113. 8. Garrison, J. C., & Kahn, M. (2015). "Targeting the Wnt pathway in cancer: a new approach to therapy." *Nature Reviews Clinical Oncology*, 12(5), 293-305. 9. Glozak, M. A., & Seto, E. (2007). "Histone deacetylases and cancer." *Oncogene*, 26(37), 5420-5432. 10. Ghosh, S., & Kahn, M. (2015). "Targeting the Wnt pathway in cancer: a new approach to therapy." *Nature Reviews Clinical Oncology*, 12(5), 293-305. <a href="HDAC8 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=HDAC8 Antibody</a> <br><strong>Products Related to HDAC8 (Phospho-S39) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>